Literature DB >> 17672950

[Expression and clinical significance of Survivin and Livin in DukesoB colorectal cancer].

Jun-He Li1, Wen-Jing He, You-Jian He.   

Abstract

BACKGROUND &
OBJECTIVE: Survivin and Livin, members of the family of inhibitor of apoptosis proteins (IAPs), are specially expressed in embryonic cells and tumor cells, but are seldom expressed in normal adult cells. Some studies showed that they are correlated to poor prognosis of some tumors. This study was to detect the expression of Survivin and Livin in DukesoB colorectal cancer, and analyze the clinical significance.
METHODS: The expression of Survivin and Livin in 81 specimens of DukesoB colorectal cancer and 12 specimens of normal colorectal tissues was detected by SP immunohistochemistry. Their correlations to clinical features and survival were analyzed.
RESULTS: The positive rates of Survivin and Livin were significantly higher in colorectal cancer than in normal colorectal tissues (58.0% vs. 16.7%, 45.7% vs. 8.3%,P < 0.05). No relationship was found between the expression of Survivin and Livin(P > 0.05). The expression of Survivin and Livin was not correlated to sex, tumor location, primary size, T stage, pathologic category, and degree of differentiation(P> 0.05). The positive rate of Survivin was significantly higher in the patients older than 50 years than in the patients younger than 50 years (70.6% vs. 36.7%, P < 0.05). Both Survivin and Livin were correlated to tumor recurrence and/or metastasis (P = 0.02, P = 0.001), and shorter survival (P = 0.039, P = 0.001). Cox multivariate analysis showed stage T4 and positive Livin expression were independent prognostic factors of DukesoB colorectal cancer (P = 0.002, P = 0.047).
CONCLUSIONS: Survivin and Livin are overexpressed in DukesoB colorectal cancer. Livin is closely related to recurrence and/or metastasis and poor prognosis of DukesoB colorectal cancer after curative resection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17672950

Source DB:  PubMed          Journal:  Ai Zheng


  4 in total

1.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

2.  Livin abrogates apoptosis of SPC-A1 cell by regulating JNKI signaling pathway.

Authors:  Yu-Sheng Chen; Hong-Ru Li; Ming Lin; Gang Chen; Bao-Song Xie; Neng-Luan Xu; Li-Fang Lin
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

3.  Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma.

Authors:  Li Chen; Guo-Sheng Ren; Fan Li; Shan-Quan Sun
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

4.  Overexpression of Livin promotes migration and invasion of colorectal cancer cells by induction of epithelial-mesenchymal transition via NF-κB activation.

Authors:  Yang Ge; Xiankui Cao; Dalu Wang; Wei Sun; Hongli Sun; Bing Han; Junpeng Cui; Baolin Liu
Journal:  Onco Targets Ther       Date:  2016-02-29       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.